About
Professor Stuart Bevan is a Professor of Pharmacology at King's College London, affiliated with the School of Neuroscience and the Department of Pharmacology. His research focuses on sensory transduction, nociception, analgesia, ion channels (particularly TRP channels), and cell signaling. His work aims to understand pain mechanisms and develop therapies for conditions like fibromyalgia, osteoarthritis, and diabetes-related pain. He collaborates with clinicians and researchers globally, including Dr. David Andersson and Dr. Andreas Goebel.
- Education: Extensive academic background in pharmacology and neuroscience (not explicitly detailed).
- Research Interests: Autoantibody roles in pain, TRP channel functions, and translational pain research.
Professor Bevan's lab investigates how sensory neurons contribute to pain in diseases like fibromyalgia and osteoarthritis. Key projects funded by MRC and Arthritis Research UK explore pain mechanisms in long-COVID, TRPM3's role in osteoarthritis, and IgG-mediated pain transfer. He has published over 60 articles, including studies on antibody-mediated autoimmunity and TRP channel regulation.
Grants & Projects:
- Pain Mechanisms in long-COVID (MRC, 2022-2026)
- TRPM3 in osteoarthritis pain (Arthritis Research UK, 2017-2022)
- Role of HCN2 ion channels in pain (ongoing)
Lab/Teams: Leads the Chronic Pain and Migraine research group within the Clinical Diagnostics Development Unit (CDDU), focusing on standardized clinical sample processing.
